Alaunos Therapeutics, INC. (TCRT) SEC Filings — 2025

Filings

• Alaunos Therapeutics, INC. 8-K Filing — 8-K · Dec 23, 2025
• Alaunos Narrows 9-Month Loss, Boosts Cash Amid Strategic Shift — 10-Q · Nov 14, 2025
• Alaunos Pivots to Obesity, Seeks $25M Amid Oncology Wind-Down — S-1 · Oct 22, 2025
• Alaunos Therapeutics Files 8-K — 8-K · Aug 20, 2025
• Alaunos Narrows Losses, Boosts Cash Amid Nasdaq Delisting Threat — 10-Q · Aug 14, 2025
• Alaunos Therapeutics Reports Board and Officer Changes — 8-K · Jul 22, 2025
• Alaunos Therapeutics Announces Board and Officer Changes — 8-K · Jul 17, 2025
• Alaunos Therapeutics Files 8-K on Security Holder Matters — 8-K · Jul 10, 2025
• Alaunos Therapeutics Faces Delisting Concerns — 8-K · Jul 2, 2025
• Alaunos Therapeutics Reports Material Definitive Agreement & Equity Sales — 8-K · Jun 26, 2025
• Alaunos Therapeutics Files 8-K on Key Agreements — 8-K · Jun 10, 2025
• Alaunos Therapeutics Files 8-K on Agreements and Equity Sales — 8-K · May 23, 2025
• Alaunos Therapeutics Files DEF 14A for 2024 — DEF 14A · May 21, 2025
• Alaunos Therapeutics Files Q1 2025 10-Q — 10-Q · May 15, 2025
• Alaunos Therapeutics Files 2024 10-K/A Amendment — 10-K/A · Apr 30, 2025
• Alaunos Therapeutics Reports Board and Executive Changes — 8-K · Apr 18, 2025
• Alaunos Therapeutics Appoints New Chief Medical Officer — 8-K · Apr 15, 2025
• Alaunos Therapeutics Files 8-K with Key Corporate Updates — 8-K · Apr 14, 2025
• Alaunos Therapeutics Faces Delisting Concerns — 8-K · Apr 11, 2025
• Alaunos Therapeutics Files 2024 10-K — 10-K · Mar 31, 2025